1. Home
  2. ONCY vs PROV Comparison

ONCY vs PROV Comparison

Compare ONCY & PROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.79

Market Cap

98.7M

Sector

Health Care

ML Signal

HOLD

Logo Provident Financial Holdings Inc.

PROV

Provident Financial Holdings Inc.

N/A

Current Price

$17.10

Market Cap

103.7M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ONCY
PROV
Founded
1998
1956
Country
Canada
United States
Employees
29
N/A
Industry
Pharmaceuticals and Biotechnology
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
98.7M
103.7M
IPO Year
2002
2009

Fundamental Metrics

Financial Performance
Metric
ONCY
PROV
Price
$0.79
$17.10
Analyst Decision
Strong Buy
Hold
Analyst Count
4
2
Target Price
$7.33
$16.25
AVG Volume (30 Days)
1.1M
5.7K
Earning Date
05-08-2026
04-28-2026
Dividend Yield
N/A
3.26%
EPS Growth
N/A
N/A
EPS
N/A
0.68
Revenue
N/A
N/A
Revenue This Year
N/A
$4.14
Revenue Next Year
$2,505.00
$3.70
P/E Ratio
N/A
$25.07
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$14.85
52 Week High
$1.51
$17.42

Technical Indicators

Market Signals
Indicator
ONCY
PROV
Relative Strength Index (RSI) 33.09 55.39
Support Level N/A $16.91
Resistance Level $1.18 $17.38
Average True Range (ATR) 0.05 0.19
MACD -0.01 -0.04
Stochastic Oscillator 12.01 33.34

Price Performance

Historical Comparison
ONCY
PROV

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

About PROV Provident Financial Holdings Inc.

Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. It is a financial services company committed to serving consumers and small to mid-sized businesses in the Inland Empire region of Southern California. Its business activities consist of community banking, investment services and trustee services for real estate transactions. The group operates in Bank segment that include attracting deposits, offering banking services and originating and purchasing single-family, multi-family, commercial real estate, construction and, to a lesser extent, other mortgage, commercial business and consumer loans. Its evenues are derived from interest earned on its loan and investment portfolios, and fees generated through its community banking activities.

Share on Social Networks: